My Size Secures $10M Equity Line of Credit with Square Gate Capital
MYSZ sits 19% above its 52-week low of $0.33 on light trading volume (0.1× avg).
Summary
My Size, Inc. entered into a $10 million equity line of credit with Square Gate Capital, providing a funding lifeline but at highly dilutive terms, including discounted share sales and a stock-based commitment fee.
Updates
· SEC S-1 — The S-1 registers 26,019,229 shares for resale: 25,000,000 ELOC shares, 269,229 initial commitment shares, and up to 750,000 true-up commitment shares if the stock closes below $0.3706 on the effective date.
Key Events · Financing and Capital Events · MYSZ
-
$10M Equity Line Secured
A 36-month Equity Purchase Agreement with Square Gate Capital now allows My Size to sell up to $10 million of common stock at its discretion.
-
Highly Dilutive Pricing Terms
The investor buys at a discount: Regular Puts are priced at 96.5% of the lowest daily VWAP over a 3-day period, while Intraday Puts are set at 100% of the lowest traded price during a 15-minute window.
-
Commitment Fee Paid in Stock
A $100,000 commitment fee was paid via 269,229 shares, with a true-up provision that could require additional shares if the stock price drops by the time the registration statement is effective.
-
Exchange Cap Limits Immediate Dilution
Issuance is capped at 1,024,597 shares, or 19.99% of outstanding, unless stockholder approval is obtained or the Average Price stays at or above $0.3706, limiting near-term dilution but also capital access.
Analysis · MYSZ · Technology
Facing a going concern warning and limited cash, My Size, Inc. has secured a critical lifeline through a $10 million equity purchase agreement with Square Gate Capital, granting the company the right to sell shares over 36 months. The terms, however, are highly dilutive: shares are sold at a discount to market—96.5% of the lowest VWAP for regular puts—and the investor receives a $100,000 commitment fee in stock. Without stockholder approval, issuance is capped at 1.02 million shares, or 19.99% of outstanding, which limits immediate dilution but also restricts the amount of capital that can be raised unless the stock price stays above $0.3706. While this financing is essential for survival, it will likely pressure the stock as shares are sold into the market.
How filings like this one have moved
In the 30 days to Oct 16, 2026, 36.6% of the 978 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.52%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MYSZ was trading at $0.39 on NASDAQ in the Technology sector, with a market capitalization of approximately $1.9M. The 52-week trading range was $0.33 to $1.48. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.